Kyle Lefkoff has changed board positions at ArcherDx, Inc.

Jun 02, 2019
Board and Executive Moves
Background Information
ArcherDX, Inc. is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO.